formoterol/fumarate/mometasone

^[1]

Indications

maintenance treatment of moderate to severe COPD
- predominantly benefits patients with elevated blood eosinophil count (> 300 x 10E6/L)^[1]

↑ ^1.0 ^1.1 Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med 2020 Aug 4; 173:ITC17 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32745458
Agusti A, Celli BR, Criner GJ et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD executive summary. Am J Respir Crit Care Med. 2023 Apr 1;207(7):819-837. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36856433 PMCID: PMC10111975 Free PMC article https://www.atsjournals.org/doi/10.1164/rccm.202301-0106PP